Philips introduces the next generation of interventional X-ray solution to South, Allura Clarity


Philips “AlluraClarity” - the next generation of interventional X-ray providing industry-leading image quality at fraction of the dose

February 26, 2013

Cape Town, South Africa  – Royal Philips Electronics (NYSE: PHG, AEX: PHIA), one of the world’s leading healthcare technology providers, today announced that it has introduced the Philips AlluraClarity interventional X-ray system to the South African market. The system was unveiled to attendees at the sixth World Congress on Paediatric Cardiology and Cardiac Surgery taking place in Cape Town, South Africa.

 

In 2011, Philips had announced the results of a clinical trial validating the revolutionary AlluraClarity with ClarityIQ technology, the next generation of interventional X-ray offering equivalent image quality at a fraction of the radiation dose. Findings from the landmark clinical trial conducted at the Karolinska Hospital in Stockholm demonstrated that Philips’ AlluraClarity with ClarityIQ technology is helping to reduce the interventional X-ray trade-off between image quality and radiation dose, underscoring Philips commitment to patient safety.
 

In the Karolinska Hospital trial, independent interventional neuro-radiologists compared images from two neurological digital subtraction angiography runs on the same patient, the first using Philips current AlluraXper system and the second using the new Philips AlluraClarity with ClarityIQ technology. The results of the study demonstrated that the AlluraClarity provides equivalent image quality at an average of 73 percent less dose.

 

Interventional imaging is a medical specialty in which minimally invasive procedures are performed to diagnose and treat diseases using image guidance. Traditionally, lower radiation dose during interventional X-ray procedures meant corresponding lower image quality, which could inhibit a clinician’s ability to accurately diagnose and treat patients. Now, with ClarityIQ technology, clinicians are finding that they can reduce patient dose without sacrificing image quality, thus enhancing their diagnostic and treatment confidence. As a result, patient and staff risks from exposure to radiation are reduced, therefore longer and more complex procedures can now be performed at less dose.

 

“Philips continuously looks for ways to reduce risk for patients and clinicians while maintaining optimal image quality. Our concern is always to help clinicians get the diagnostic information they need at a low dose said Jose Fernandes, District Manager, Philips Healthcare Southern Africa “Philips has already experienced incredible success with iDose technology in diagnostic CT scanners that has been introduced into both The Donald Gordon Medical Institute and Sunninghill Hospital, in Johannesburg”

For further information, please contact:

Radhika Choksey
Philips Corporate Communications
Tel: +31 62525 9000
Email: radhika.choksey@philips.com

About Royal Philips Electronics

Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 118,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming, home and portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.